TY - JOUR
T1 - Smoking-related idiopathic interstitial pneumonia
T2 - A review
AU - Margaritopoulos, George A.
AU - Harari, Sergio
AU - Caminati, Antonella
AU - Antoniou, Katerina M.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - For many years, cigarette smoking has been considered as the leading cause of chronic obstructive pulmonary disease and lung cancer. Recently, however, it has also been associated with the development of diffuse interstitial lung diseases. In the latest classification of the major idiopathic interstitial pneumonias (IIP), the term smoking-related IIP has been introduced, including two entities, namely desquamative interstitial pneumonia (DIP) and respiratory bronchiolitis-interstitial lung disease (RB-ILD). Other entities in which smoking has a definite or suggested role include pulmonary Langerhan's cell histiocytosis, smoking-related interstitial fibrosis, combined pulmonary fibrosis and emphysema syndrome and idiopathic pulmonary fibrosis. In this review, we will focus on the mechanisms of smoking-related lung damage and on the clinical aspects of these disorders with the exception of idiopathic pulmonary fibrosis, which will be reviewed elsewhere in this review series. Multiple small, irregularly shaped, cysts of varying sizes are present with thin walls in the upper lung lobes of patients with pulmonary Langerhans cell histiocytosis (PLCH; Left). A high magnification micrograph of Langerhans cell histiocytosis shows that Langerhans type histiocytes are CD1a dendritic cells in the lung with a reniform (or kidney-shaped) nucleus (Right).
AB - For many years, cigarette smoking has been considered as the leading cause of chronic obstructive pulmonary disease and lung cancer. Recently, however, it has also been associated with the development of diffuse interstitial lung diseases. In the latest classification of the major idiopathic interstitial pneumonias (IIP), the term smoking-related IIP has been introduced, including two entities, namely desquamative interstitial pneumonia (DIP) and respiratory bronchiolitis-interstitial lung disease (RB-ILD). Other entities in which smoking has a definite or suggested role include pulmonary Langerhan's cell histiocytosis, smoking-related interstitial fibrosis, combined pulmonary fibrosis and emphysema syndrome and idiopathic pulmonary fibrosis. In this review, we will focus on the mechanisms of smoking-related lung damage and on the clinical aspects of these disorders with the exception of idiopathic pulmonary fibrosis, which will be reviewed elsewhere in this review series. Multiple small, irregularly shaped, cysts of varying sizes are present with thin walls in the upper lung lobes of patients with pulmonary Langerhans cell histiocytosis (PLCH; Left). A high magnification micrograph of Langerhans cell histiocytosis shows that Langerhans type histiocytes are CD1a dendritic cells in the lung with a reniform (or kidney-shaped) nucleus (Right).
KW - diagnosis
KW - fibrosis
KW - inflammation
KW - nicotine
KW - smoking
KW - therapy
UR - http://www.scopus.com/inward/record.url?scp=84952870639&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84952870639&partnerID=8YFLogxK
U2 - 10.1111/resp.12576
DO - 10.1111/resp.12576
M3 - Article
C2 - 26138798
AN - SCOPUS:84952870639
VL - 21
SP - 57
EP - 64
JO - Respirology
JF - Respirology
SN - 1323-7799
IS - 1
ER -